In the past decades, growing evidence from clinical and laboratory studies has linked insulin resistance to neurodegenerative disorders, such as Parkinson’s disease (PD) and Alzheimer’s disease (AD) (Schubert et al., 2004; Athauda and Foltynie, 2016; Tumminia et al., 2018). Here, INS is linked to Parkinson disease.